Vaccines play a pivotal role in preventing various infections caused by fungi, bacteria, viruses, parasites, and sexually transmitted diseases (STDs). While fungal infections like candidiasis and aspergillosis are often managed with antifungal medications, ongoing research aims to develop vaccines for specific fungal pathogens. Bacterial vaccines, such as those targeting bacteria like Streptococcus pneumoniae or Neisseria meningitidis, help prevent illnesses like pneumonia or meningitis. Vaccines against viral infections like influenza, measles, or HPV have significantly reduced disease burdens worldwide. Similarly, ongoing efforts toward parasitic disease vaccines, such as those against malaria or leishmaniasis, aim to curb the impact of these infections. Moreover, vaccines against STDs like human papillomavirus (HPV) and hepatitis B play a crucial role in preventing transmission and reducing associated health risks, emphasizing the importance of vaccination in comprehensive disease prevention strategies.
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey